EMERALD ADVISERS, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001015083
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2023 · 242 positions · Total reported value $2.34B · Top-10 concentration 19.4% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 51.0% · 14 new · 86 cut · 28 exited
Active Share (vs S&P 500): 97.9% · vs QQQ: 98.3% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -14.5% · vs SPY -16.6% · Prev Value $4.25B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -4.4% · vs SPY -6.6% · Latest Value $3.63B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q4 2023 13F filing, EMERALD ADVISERS, LLC disclosed 242 equity positions with a combined reported value of $2.34B. The filing implies a diversified portfolio: its ten largest positions account for 19.4% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.
The largest disclosed positions as of Q4 2023 were IMGN ($51.74M), ACAD ($51.52M), FRPT ($48.80M). By sector, the heaviest allocations are Health Care 21.5%, Technology 19.4%. Versus the prior quarter, allocation shifted toward Technology (+2.4pp), Financials (+1.2pp) and away from Health Care (-0.7pp), Consumer Staples (-0.7pp).
Versus the prior quarter, EMERALD ADVISERS, LLC opened 14 new positions, trimmed 86 and fully exited 28, a turnover rate of 51.0% of positions. The portfolio's overlap with the prior quarter was 84% of names.
The largest new positions opened in Q4 2023 were QTWO ($17.01M), IMVT ($12.90M), IBP ($12.37M).
Of the 28 positions fully exited versus the prior quarter, the largest were MODN ($15.02M), EVRI ($14.65M), NXT ($11.04M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2023)
- QTWO Q2 HLDGS INC · $17.01M
- IMVT IMMUNOVANT INC · $12.90M
- IBP INSTALLED BLDG PRODS INC · $12.37M
- BANC BANC OF CALIFORNIA INC · $10.98M
- DCPH DECIPHERA PHARMACEUTICALS IN · $10.83M
- KLIC KULICKE & SOFFA INDS INC · $8.13M
- LNWO LIGHT & WONDER INC · $7.74M
- ATEC ALPHATEC HLDGS INC · $7.34M
Fully Exited (vs previous quarter)
- MODN MODEL N INC · prev qtr: $15.02M
- EVRI EVERI HLDGS INC · prev qtr: $14.65M
- NXT NEXTPOWER INC · prev qtr: $11.04M
- BW BABCOCK & WILCOX ENTERPRISES · prev qtr: $8.74M
- SGEN SEAGEN INC · prev qtr: $818.69K
- SRPT SAREPTA THERAPEUTICS INC · prev qtr: $418.69K
- HLX HORNBECK OFFSHORE SERVICES I · prev qtr: $410.92K
- OC OWENS CORNING NEW · prev qtr: $338.84K
Insider Transactions (Form 4)
Latest EMERALD ADVISERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Emerald Advisers is an SEC-registered 13F filer based in Leola, PA, United States. As of Q2 2026 it reported 237 US equity positions with a combined value of $4.25B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: LEOLA, PA, United States
- SEC registration: 801-40263 (status: Approved), registered 1991-11-25
- Regulatory AUM (Form ADV): $3.30B as of 2026-03-31
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Website: teamemerald.com
Portfolio Structure
- 237 positions · $4.25B reported value (Q2 2026)
- Top 10 holdings = 17.4% of reported value
- Largest position: TVTX (TRAVERE THERAPEUTICS INC) at 2.1%
- Average position size: $17.93M
Sector Tilt
- Information Technology 26.5%
- Health Care 21.7%
- Consumer Discretionary 19.5%
- (classified holdings cover 99% of value)
Quarterly Activity
- Q2 2026: 28 new, 76 added, 81 reduced, 39 exited
- 52 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.74M | $51.74M | 2.21% | Reduce | |
| 2 |
|
1.65M | $51.52M | 2.21% | Reduce | |
| 3 |
|
562.47K | $48.80M | 2.09% | Add | |
| 4 |
|
674.56K | $47.76M | 2.04% | Reduce | |
| 5 |
|
154.00K | $43.78M | 1.87% | Add | |
| 6 |
|
322.25K | $43.48M | 1.86% | Reduce | |
| 7 |
|
954.45K | $43.22M | 1.85% | Reduce | |
| 8 |
|
466.43K | $43.02M | 1.84% | Reduce | |
| 9 |
|
516.35K | $40.76M | 1.74% | Add | |
| 10 |
|
848.94K | $39.39M | 1.69% | Reduce | |
| 11 |
|
846.20K | $38.98M | 1.67% | Add | |
| 12 |
|
500.86K | $37.23M | 1.59% | Reduce | |
| 13 |
|
1.81M | $36.66M | 1.57% | Reduce | |
| 14 |
|
252.03K | $34.36M | 1.47% | Hold | |
| 15 |
|
291.60K | $32.40M | 1.39% | Reduce | |
| 16 |
|
1.90M | $30.71M | 1.31% | Reduce | |
| 17 |
|
244.15K | $29.04M | 1.24% | Reduce | |
| 18 |
|
229.04K | $28.87M | 1.24% | Reduce | |
| 19 |
|
930.85K | $28.85M | 1.24% | Reduce | |
| 20 |
|
371.61K | $28.23M | 1.21% | Reduce | |
| 21 |
|
685.54K | $27.68M | 1.18% | Reduce | |
| 22 |
|
789.57K | $26.75M | 1.15% | Add | |
| 23 |
|
280.10K | $26.03M | 1.11% | Reduce | |
| 24 |
|
557.39K | $25.34M | 1.08% | Hold | |
| 25 |
|
451.04K | $25.32M | 1.08% | Reduce | |
| 26 |
|
488.44K | $25.27M | 1.08% | Reduce | |
| 27 |
|
1.07M | $25.24M | 1.08% | Add | |
| 28 |
|
166.84K | $24.84M | 1.06% | Reduce | |
| 29 |
|
445.33K | $24.72M | 1.06% | Reduce | |
| 30 |
|
394.73K | $24.63M | 1.05% | Reduce | |
| 31 |
|
343.82K | $24.62M | 1.05% | Reduce | |
| 32 |
|
358.69K | $24.48M | 1.05% | Reduce | |
| 33 |
|
754.86K | $24.26M | 1.04% | Add | |
| 34 |
|
153.60K | $23.49M | 1.00% | Add | |
| 35 |
|
561.89K | $23.44M | 1.00% | Add | |
| 36 |
|
1.19M | $23.17M | 0.99% | Add | |
| 37 |
|
482.14K | $23.06M | 0.99% | Reduce | |
| 38 |
|
710.46K | $22.83M | 0.98% | Reduce | |
| 39 |
|
983.51K | $22.65M | 0.97% | Add | |
| 40 |
|
566.33K | $22.43M | 0.96% | Reduce | |
| 41 |
|
2.71M | $21.97M | 0.94% | Reduce | |
| 42 |
|
888.22K | $21.33M | 0.91% | Reduce | |
| 43 |
|
586.41K | $21.12M | 0.90% | Reduce | |
| 44 |
|
251.62K | $20.54M | 0.88% | Add | |
| 45 |
|
666.10K | $20.50M | 0.88% | Reduce | |
| 46 |
|
1.17M | $20.27M | 0.87% | Add | |
| 47 |
|
346.02K | $19.76M | 0.85% | Reduce | |
| 48 |
|
164.21K | $19.69M | 0.84% | Reduce | |
| 49 |
|
1.18M | $19.60M | 0.84% | Add | |
| 50 |
|
356.52K | $19.47M | 0.83% | Add | |
FAQ
What did EMERALD ADVISERS, LLC buy in 2023-Q4?
In its 2023-Q4 13F filing, EMERALD ADVISERS, LLC reported 242 equity positions worth $2.34B in aggregate; its largest disclosed positions were IMGN ($51.74M), ACAD ($51.52M), FRPT ($48.80M).
How large is EMERALD ADVISERS, LLC's portfolio?
EMERALD ADVISERS, LLC reported $2.34B of long equity holdings across 242 positions as of 2023-Q4. Top-10 holdings account for 19.4% of reported value.
What is EMERALD ADVISERS, LLC's investment style?
HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.